An abnormal blood pressure (BP) response to clinical exercise testing is useful in cardiovascular disease (CVD) risk prediction. Exercise hypotension is a sign of existing and likely severe cardiorespiratory disease. On the other hand, exercise hypertension also carries elevated CVD risk, but with a different aetiology related to underlying high BP gone undetected by traditional BP measures at rest. This webinar aims to provide an update on available research evidence, highlighting the clinical and prognostic relevance of measuring exercise BP in clinical practice. It also aims to provide AEP participants with practical knowledge and skills surrounding exercise BP, its underlying physiology and clinical measurement.
Dr Martin Schultz is an NHMRC Early Career Research Fellow at the Menzies Institute for Medical Research, University of Tasmania, Hobart, where he performs research aimed at determining the clinical relevance and underlying physiology associated with high blood pressure (hypertension) in response to exercise. Dr Schultz is also an Exercise & Sports Science Australia (ESSA) accredited exercise physiologist and undertakes regular clinical work.
|ESSA Student Member||$15.00|
|ESSA Member PD Voucher||Complimentary|
Places are limited. Registration closes at 3:00pm AEST, Monday, 25 September 2017.
Monday, 25 September 2017
at 6:30pm – 8:00pm AEST
Target Audience: Any Accredited Exercise Physiologist
Audience Disclaimer: All accredited persons, regardless of any professional development completed/attended must refer to their accreditation’s Scope of Practice, and only treat/practice within the same.
Access: Information to access the webinar will be forwarded to you within your registration confirmation email.
Or download the Manual Registration Form